House TrueBlot GOC
 

News:

Improve Your Cancer Research Results with Rockland HDAC Antibodies

Date Posted:
2014-02-11
 HDACs are among the most promising therapeutic targets for cancer treatment. Rockland produces highly specific HDAC antibodies for histone assays that can help pinpoint intracellular reactions related to cancer growth. To learn more, visit our website or contact us today. View the Full Newsletter